Cowen & Co. TD Cowen Initiates Coverage of MDxHealth With Outperform Rating Analyst Dan Brennan wrote in a note to investors that the company's position in an under-penetrated market bodes well for future revenue growth. TD Cowen Upgrades Shares of Pacific Biosciences to Outperform A survey revealed that labs with multiple PacBio Sequel instruments plan to buy an average of three Revio sequencers each, TD Cowen Analyst Dan Brennan said. Pacific Biosciences to Raise $175M in Public Stock Offering The company is selling 17.5 million shares of its common stock at a price of $10 per share in the offering, which is expected to close Jan. 27. Cowen Initiates Coverage of 23andMe With Outperform Rating The investment bank pointed to 23andMe's unique and hard-to-replicate population-scale genetic database as a key growth driver. Cowen Initiates Coverage of Ginkgo Bioworks With Outperform Rating Ginkgo Bioworks went public in September through a SPAC merger, raising $1.63 billion in proceeds. Cowen joins BTIG in covering shares of the firm. Dec 16, 2021 Cowen Initiates Coverage of NeoGenomics at Outperform Aug 17, 2021 JP Morgan, Cowen Initiate Coverage of Sophia Genetics With Overweight, Outperform Ratings Jun 21, 2021 JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems May 24, 2021 Singular Genomics Ups IPO Target to $187M May 12, 2021 Sequencing Startup Singular Genomics Files for $100M IPO Mar 15, 2021 Roche to Acquire GenMark Diagnostics for $1.8B Dec 3, 2020 Twist Bioscience Prices Upsized $300M Public Offering Dec 2, 2020 Twist Bioscience Proposes $250M Public Offering Oct 8, 2020 NanoString Technologies Prices $200M Public Offering Oct 7, 2020 NanoString Technologies Q3 Preliminary Product, Service Revenues Grow 14 Percent Sep 21, 2020 Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider Premium Sep 11, 2020 10x Genomics Prices Upsized $440M Public Offering Sep 9, 2020 10x Genomics to Sell 3.5M Shares in Public Offering Aug 12, 2020 Pacific Biosciences Prices $86.9M Public Stock Offering Aug 11, 2020 JP Morgan, Cowen, William Blair Initiate Coverage of Berkeley Lights Jul 17, 2020 Berkeley Lights Prices Upsized $178.2M IPO Jul 16, 2020 Adaptive Biotechnologies to Raise $240M in Public Stock Offering Jun 4, 2020 Twist Bioscience Prices $100M Stock Offering Feb 19, 2020 Twist Bioscience Announces $100M Public Stock Offering Jan 24, 2020 Adaptive Biotechnologies Prices Public Offering of Stock Load More Breaking News Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis Evvy Closes $14M Series A for Vaginal Microbiome Testing, Launches Add-on STI Screen Consanguinity Contributes to Common Disease Risk, Study Suggests Ginkgo Bioworks, Pfizer Ink RNA Drug Discovery Deal Worth up to $331M The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.